Supply Chain

A recent decision by the Food and Drug Administration will allow Keryx Biopharmaceuticals to overcome a large obstacle in the manufacturing of its kidney drug Auryxia, according to the Boston Business Journal.

The Food and Drug Administration is in the midst of a two-day hearing to discuss whether drug companies and devicemakers should be allowed to promote unapproved uses of medical products to physicians, reports Star Tribune.

While a majority of the trucking industry is scaling back on shipping capacities due to low demand and weak pricing throughout most of 2016, Lowell, Ark.-based J.B. Hunt Transport Services will add hundreds of trucks to its fleet in 2017, reports…

The Chartered Institute of Procurement & Supply Risk Index shows risk is growing in global supply chains.

The recent closure of a Canadian nuclear reactor could diminish the global supply of a radioactive material used in medical imaging tests, according to Inside Science.

California voted down a ballot initiative to tackle the rising costs of prescription drugs, reports Reuters.

President-elect Donald Trump's unexpected win Tuesday night served up a large dose of uncertainty for U.S. businesses with rumors of updated trade pacts and crackdowns on overseas manufacturing operations circling his campaign platform.

Hospitals selecting an asset tracking system should choose their system based on cost-savings, user-friendly capability and speed, according to PV Subramanian, CEO of Visybl.

Arcadia Healthcare Solutions recently released a new tool allowing users to examine a drug's changes in frequency of prescriptions and price over the last five years. The resource contains information for more than 60,000 different formulations and drug products, based on…

British devicemaker BTG and its subsidiary Biocompatibles will pay $36 million to resolve false claims allegations surrounding the off-label promotion of its medical device LC Bead.